Synthetic compound may treat skin cancer, study says

A U.S. study revealed that administering topical or injected versions of a synthetic compound called CP-31398 helps treat the damage in the tumor-suppressing p53 gene in mice exposed to ultraviolet B rays, leading to the prevention of skin cancer development and inhibition of tumor growth in mice. Research on the compound could lead to development of a more-effective cream or sunblock designed to protect against skin cancer, a doctor said.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID